OPTISON perflutren 660 microgram/3mL injection vial

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

perflutren, Quantity: 190 microgram/mL

Pieejams no:

GE Healthcare Australia Pty Ltd

Zāļu forma:

Injection, suspension

Kompozīcija:

Excipient Ingredients: Albumin; sodium chloride; N-acetyltryptophan; octanoic acid; sodium hydroxide; water for injections

Ievadīšanas:

Intravenous

Vienības iepakojumā:

5 vials

Receptes veids:

Not scheduled. Not considered by committee

Ārstēšanas norādes:

OTHER CONDITIONS: Store vial upright. OPTISON is indicated for use in patients with inclusive exchocardiograms to opacify the left ventricle and to improve the delineation to the left ventricular endocardial borders.

Produktu pārskats:

Visual Identification: Clear liquid lower layer with a white upper layer.; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2000-11-15